In summary, our work shows that CMBs, WMLs, APOE ε4 carrier status, hydrocephalus and/or seizures at baseline may serve as markers for long-term cognitive dysfunction in pediatric cancer survivors, especially in patients with CNS tumors previously treated with radiation. The gene discussed is APOE; the disease is central nervous system neoplasm.